IDiyas

For the Inventor, By the Inventor

Shanghai, China

Zhiqi Qi

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal7 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents

Years Active: 2017-2020

Loading Chart...
Loading Chart...
7 patents (USPTO):
1. 10745377 - Piperidine or piperazine linked imidazole and triazole derivatives and methods of use (2020-08-18),
2. 10556900 - TrkA kinase inhibitors, compositions and methods thereof (2020-02-11),
3. 9981969 - Imidazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug (2018-05-29),
4. 9975888 - Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug (2018-05-22),
5. 9862707 - TrkA kinase inhibitors, compositions and methods thereof (2018-01-09),
6. 9815846 - TrkA kinase inhibitors, compositions and methods thereof (2017-11-14),
7. 9556202 - Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug (2017-01-31),

Title: Zhiqi Qi: Innovator in Pharmaceutical Chemistry

Introduction

Zhiqi Qi is a prominent inventor based in Shanghai, China, known for his significant contributions to pharmaceutical chemistry. With a total of seven patents to his name, Qi has made remarkable advancements in the field, particularly in drug development and pharmacokinetics.

Latest Patents

Among his latest patents, Qi has developed piperidine or piperazine linked imidazole and triazole derivatives. This invention relates to compounds that improve the pharmacokinetics of drugs, particularly those metabolized by CYP3A4. These compounds are valuable in both human and veterinary medicine. Another notable patent is focused on TrkA kinase inhibitors, which are bicyclic heteroaryl benzamide compounds. These inhibitors are useful in treating various conditions, including pain, inflammation, and cancer.

Career Highlights

Zhiqi Qi has worked with notable companies such as Merck Sharp & Dohme Corporation and MSD R&D Co., Ltd. His work in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Qi has collaborated with esteemed colleagues, including Chun Sing Li and Craig Alan Coburn. These partnerships have fostered innovation and have been instrumental in advancing his research.

Conclusion

Zhiqi Qi's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to impact drug development and improve therapeutic outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…